New Drug Targets Bone Disease That Causes Hearing Loss
The drug LGK974, which inhibits the Wnt signaling pathway, shows promise in reversing excessive bone growth in sclerosteosis.
The drug LGK974, which inhibits the Wnt signaling pathway, shows promise in reversing excessive bone growth in sclerosteosis.
Researchers at EPFL have developed a soft, thin-film auditory brainstem implant (ABI) that shows promise for more precise hearing restoration compared to rigid conventional implants.
A study found the brain can enhance cochlear sensitivity to compensate for hearing loss in mice, potentially leading to new treatments for hearing disorders like hyperacusis and tinnitus.
Investigational gene therapy DB-OTO showed promising improvements in hearing and speech development in children with otoferlin-related genetic hearing loss.
Read MoreAudiologist De Wet Swanepoel received the award for his research on mobile hearing care, which aims to expand access to underserved communities worldwide.
Read MoreThe new μETF one-step fabrication method improves the design of flexible 3D microelectrode arrays for neural applications.
Read MoreThe study aims to develop auditory biomarkers for early detection and improved management of Alzheimer’s and Parkinson’s disease.
Read MoreEven though humans’ auricular muscles are vestigial, they still activate when we strain to listen, suggesting they may play a role in auditory attention.
Read MoreEnvoy Medical has chosen seven investigational sites for its pivotal clinical trial of the fully implanted Acclaim cochlear implant.
Read MoreThe Hearing Health Foundation’s research grants program is offering seed funding for researchers advancing hearing and balance science.
Read MoreResearchers identified a previously unknown set of cochlear modes that refine our understanding of how the human ear assesses sounds.
Read MoreSignGPT is a project aimed at using generative AI to bridge communication gaps between sign language and spoken languages.
Read MoreA study highlights a correlation between hearing loss and an increase in Parkinson’s risk, highlighting a need to address auditory health.
Read MoreResearchers have identified and mapped diverse cell types in the cochlear nucleus, a critical part of the auditory system, advancing understanding of how our brains process sounds and paving the way for targeted treatments for auditory disorders.
Read MoreResearchers identified a key driver of susceptibility to “glue ear” in individuals with Down syndrome, paving the way for targeted therapies to address hearing loss.
Read MoreA study offers insights into how vibration sensing could compensate for hearing loss and inform sensory prosthetic development.
Read MoreResearchers developed an AI system using MediaPipe and YOLOv8, achieving 98% accuracy in detecting American Sign Language (ASL) gestures.
Read MoreGene regulators in fish and lizards that regenerate hearing may pave the way for future therapies targeting hearing loss in humans.
Read More